From Development to Delivery: Comprehensive Project Management for Functional VPs
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBiologic
Tap our proven, successful approach to responding to cold chain-related regulatory inquiries.
Request a ConsultationGood communication is vital to getting your drug product reviewed and approved without delay. And the more novel or advanced your therapy, the greater the odds that regulators will have questions or request more data. When regulators present an Information Request (IR), complete response review letter (CRL), or other inquiry, Modality Solutions can draft a rapid, effective response designed to keep your filing moving forward.
Modality Solutions is the right partner to help you respond to regulatory inquiries appropriately, reduce potential delays, adhere to accelerated deadlines, and keep your therapy’s review and approval on track. We’ve worked with dozens of drug products on accelerated pathways—including Fast Track, Breakthrough Therapy, Regenerative Medicine Advanced Therapy, Advanced Approval, and Priority Review.
Solid technical writing is a unique craft—one our engineers have perfected through many years of drafting technical assessments for thermal packaging, validation test data technical reports, regulatory responses, SOPs for pack-out and other procedures, operational qualification (OC) and performance qualification (PQ) protocols and data packages, and training documentation. On every emergency response project, we couple our extensive technical writing experience with careful analysis and unmatched knowledge of ever-evolving global cold chain regulations and guidance.
The result: A proven track record of successful responses to regulatory inquiries, for the most advanced therapeutics, on accelerated timelines.
When a regulatory inquiry threatens to slow your drug product’s filing, you can’t risk a response that’s not complete, effective, and timely. With unrivaled cold chain expertise and technical writing experience, Modality Solutions is uniquely qualified to help you respond to emergency requests in a way that maximizes the odds of a fast, successful filing.
What makes Modality Solutions the right choice for the most effective emergency response to your regulatory inquiries?
During its BLA filing for TRODELVY™, an antibody-drug conjugate (ADC) therapy for triple negative breast cancer, Immunomedics received several Information Requests (IRs) about its cold chain validation strategy. To respond effectively and keep its accelerated approval planson track, the company turned to Modality Solutions. In just two weeks, our engineers mapped the supply chain, conducted a risk assessment, developed a risk mitigation strategy…
Read the case study nowWhen regulators pose questions or need clarification about your drug filing, Modality Solutions can bring our full range of technical capabilities and engineering solutions to bear.
See which solutions are right for your therapeutic type and your current clinical phase.
When a pharmaceutical manufacturer or biopharmaceutical company is preparing to file an NDA or BLA, Modality Solutions applies capabilities like these to keep promising new therapeutics advancing through the review and approval process.
Cold Chain Engineering
Learn MoreAI-Driven Cold Chain Optimization
Learn MoreTransport Simulation Lab
Learn MoreIn the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBiologic
You’ve submitted a new drug application (NDA) or a biologics license application (BLA) for...
read DetailsEmergency Response
When your mAb or other biologic is moving through the Biologics License Application (BLA)...
read DetailsBiologic